Private-equity firm KKR & Co. is nearing a deal to sell Capsugel to Switzerland's Lonza Group AG for more than $5 billion, as an auction of the New Jersey drug-capsule maker draws to a close. Lonza is currently the leading bidder, according to people familiar with the matter, though one of them cautioned that a deal isn't guaranteed and others may still be circling.
